All stocks Β· PARNAXLAB
PL

Parnax Lab Limited

PARNAXLAB BSE Drug Manufacturers - Specialty & Generic Healthcare

Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, …

ISIN INE383L01019
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products. It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provides drug identification and development services; in- and out-licensing services; and contract research and manufacturing services The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.

Key Metrics

as of Sep 2026
Market Cap156 Cr
P/E15.60
Div Yield0.00 %
Book Valueβ‚Ή82.80
52w Highβ‚Ή182.00
52w Lowβ‚Ή99.20
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 56.80 69.63 62.94 62.60 53.38 49.04 40.22 48.36 50.12 46.37 50.99 42.61 48.74
Expenses 52.49 64.75 56.09 54.52 45.94 42.41 35.95 41.12 41.50 40.58 45.02 37.32 42.24
Operating Profit 4.31 4.88 6.85 8.08 7.44 6.63 4.27 7.24 8.62 5.79 5.97 5.29 6.50
OPM % 7.59 7.01 10.88 12.91 13.94 13.52 10.62 14.97 17.20 12.49 11.71 12.41 13.34
Other Income 0.15 1.76 -0.17 0.63 0.18 0.43 0.19 0.95 0.11 0.25 0.10 0.22 0.24
Depreciation 2.22 2.04 1.96 2.10 1.94 1.83 1.79 1.94 1.83 1.84 1.78 1.74 1.60
Interest 1.64 1.61 1.47 1.40 1.22 1.28 1.23 1.38 1.50 1.41 1.35 1.43 1.16
Profit before tax 0.60 2.99 3.25 5.21 4.46 3.95 1.44 4.87 5.40 2.79 2.94 2.34 3.98
Tax % 28.33 27.09 16.62 30.33 26.46 26.08 16.67 29.77 26.30 19.35 25.85 20.09 16.33
Net Profit 0.43 2.19 2.71 3.62 3.28 2.93 1.21 3.42 3.99 2.24 2.18 1.87 3.33
EPS in Rs 0.37 1.90 2.36 3.16 2.85 2.54 1.05 2.97 3.47 1.95 1.90 1.63 2.89

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 249.00188.00189.00168.00163.0090.0095.00109.00106.0095.0071.00103.00
Expenses 221.00161.00165.00145.00140.0080.0089.0099.0095.0082.0061.0091.00
Operating Profit 27.0027.0024.0023.0023.0010.006.0010.0010.0013.0010.0012.00
OPM % 11.0014.0012.0014.0014.0011.007.009.0010.0014.0014.0012.00
Other Income 2.001.001.001.000.000.001.002.001.000.001.001.00
Interest 6.005.005.005.005.005.005.004.004.005.004.004.00
Depreciation 8.007.007.007.006.005.004.004.004.004.003.003.00
Profit before tax 16.0016.0012.0012.0012.000.00-2.005.003.005.003.005.00
Tax % 26.0026.0020.0030.0033.00350.0048.0028.0065.0022.0028.0022.00
Net Profit 12.0012.0010.009.008.000.00-3.003.001.004.003.004.00
EPS in Rs 10.2610.038.377.518.40-0.42-3.423.881.234.332.955.01
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 11.0011.0011.0011.0010.008.008.008.008.008.008.008.00
Reserves 84.0072.0060.0051.0038.0024.0024.0027.0024.0023.0019.0017.00
Borrowings 83.0070.0081.0055.0069.0059.0051.0042.0037.0039.0042.0041.00
Other Liabilities 50.0037.0038.0028.0036.0015.0023.0017.0018.0015.0010.0017.00
Total Liabilities 228.00190.00190.00145.00153.00106.00107.0095.0087.0086.0079.0083.00
Fixed Assets 115.0088.0089.0077.0072.0060.0058.0051.0044.0047.0038.0036.00
CWIP 11.0029.0021.002.003.005.003.000.000.000.002.001.00
Investments 0.000.000.000.000.000.000.000.000.000.001.001.00
Other Assets 101.0072.0080.0066.0078.0041.0046.0043.0043.0038.0038.0045.00
Total Assets 228.00190.00190.00145.00153.00106.00107.0095.0087.0086.0079.0083.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 8.0032.0016.0021.009.006.009.009.0013.0016.003.000.00
Cash from Investing Activity -16.00-16.00-32.00-10.00-16.00-7.00-13.00-11.00-5.00-10.00-6.00-4.00
Cash from Financing Activity 8.00-16.0015.00-14.0012.000.005.001.00-7.00-5.001.006.00
Net Cash Flow 0.000.00-1.00-3.004.000.000.00-1.001.000.00-2.001.00
Free Cash Flow -9.0016.00-16.0011.00-8.000.00-4.00-3.008.005.00-3.00-4.00
CFO/OP % 42.00130.0079.00103.0038.0071.00153.0099.00134.00134.0046.0015.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 56.0060.0063.0061.0085.0068.0088.0064.0065.0072.00100.0084.00
Inventory Days 90.0087.0094.0079.0073.0080.0076.0052.0045.0050.0064.0038.00
Days Payable 80.0072.0074.0053.0081.0046.0074.0044.0045.0048.0030.0051.00
Cash Conversion Cycle 65.0075.0083.0086.0077.00102.0090.0072.0064.0074.00134.0071.00
Working Capital Days -11.00-24.00-23.00-19.00-35.00-66.00-31.000.00-8.00-26.007.0016.00
ROCE % 14.0014.0013.0015.0017.006.003.0012.0011.0014.0011.0016.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 72.30 72.30 72.30 72.30 72.30 72.30 72.30 72.30 72.30 72.30 72.30 72.30
Public 27.71 27.71 27.70 27.71 27.70 27.70 27.71 27.71 27.70 27.70 27.70 27.69
No. of Shareholders 3,572 3,721 3,900 4,111 4,317 4,440 4,521 4,173 4,406 4,496 3,536 3,543

Corporate Actions

No corporate actions recorded.

Announcements

5 filings